发明名称 ACTIVATED T-CELLS AND THEIR USES
摘要 The present invention relates to compositions and methods for the treatment or diagnosis of injury of the central nervous system (CNS). In particular, the invention relates to compositions comprising activated T-cells which are used to deliver (a) a diagnostic substance or (b) a therapeutic substance to a site of damage of the CNS caused by injury or disease. The invention also relates to pharmaceutical compositions comprising antiself T-cells that recognize antigens present in a greater concentration in the CNS compared to the circulation and methods of use thereof to prevent or inhibit degeneration of nerves within the CNS. The invention also relates to pharmaceutical compositions comprising an antigen (or derivative thereof) present in a greater concentration in the CNS compared to the circulation (NS-specific antigen or derivative) and methods of use thereof to prevent or inhibit degeneration of nerves within the CNS. The substance-delivering activated Tcell composition of the present invention may be administered alone or in combination with NS-specific T-cells or NS-specific antigen or in combination with NS-specific T-cells and NS-specific antigen.
申请公布号 CA2296999(A1) 申请公布日期 1999.07.15
申请号 CA19982296999 申请日期 1998.07.21
申请人 YEDA RESEARCH AND DEVELOPMENT CO. LTD. 发明人 EISENBACH-SCHWARTZ, MICHAL;COHEN, IRUN R.;HIRSCHBERG, DAVID L.
分类号 C12N15/09;A01N63/00;A61K;A61K35/12;A61K35/28;A61K38/00;A61K38/17;A61K39/00;A61K39/35;A61K45/00;A61K48/00;A61K49/00;A61K51/00;A61P9/10;A61P17/02;A61P21/02;A61P25/14;A61P25/16;A61P25/28;A61P27/06;C12N5/10 主分类号 C12N15/09
代理机构 代理人
主权项
地址